The alchemist
VIP
https://www.med.hku.hk/en/news/press/20211215-omicron-sars-cov-2-infection
They used tissue from those areas of research in a controlled lab environment, studying the effects the normal, delta, and omicron effects have on those ex vivo cultures. The results seem to be of good news in some sense, omicron replicates 70 times faster in the bronchus and can be the reason why it spreads faster, but does so ten times slower in the lungs, causing less severity for the potential of a strong and deadly disease.
The are limitations to this study. First, it is not peer-reviewed yet. Second, it is not studied and observed on live human cohort. These points are important to take note of because there can be unforeseen spaces and combinatory biological phenomena interplay and broad human behavioral patterns as well as receptive nature of each individual immunological profile that can potentially give rise to other outcomes in the real world which those controlled environment studies with no humans involved is limited by.
There have been some reports from some countries that back these milder cold-like symptoms from omicron, but I think there was a situation where a person with Omicron in Denmark had a serious case if I recall correctly. We will have to see how things turn out in the coming weeks.
If how it is observed in that study corresponds with how it plays out among people, then omicron still will have a lot higher and faster spread capacity and make a lot more people catch the virus. Though lower, probabilistically some people will still get serious disease and unfortunately die as it will reach a lot more people. Only Allah knows best and we will have to see and wait.
They used tissue from those areas of research in a controlled lab environment, studying the effects the normal, delta, and omicron effects have on those ex vivo cultures. The results seem to be of good news in some sense, omicron replicates 70 times faster in the bronchus and can be the reason why it spreads faster, but does so ten times slower in the lungs, causing less severity for the potential of a strong and deadly disease.
The are limitations to this study. First, it is not peer-reviewed yet. Second, it is not studied and observed on live human cohort. These points are important to take note of because there can be unforeseen spaces and combinatory biological phenomena interplay and broad human behavioral patterns as well as receptive nature of each individual immunological profile that can potentially give rise to other outcomes in the real world which those controlled environment studies with no humans involved is limited by.
There have been some reports from some countries that back these milder cold-like symptoms from omicron, but I think there was a situation where a person with Omicron in Denmark had a serious case if I recall correctly. We will have to see how things turn out in the coming weeks.
If how it is observed in that study corresponds with how it plays out among people, then omicron still will have a lot higher and faster spread capacity and make a lot more people catch the virus. Though lower, probabilistically some people will still get serious disease and unfortunately die as it will reach a lot more people. Only Allah knows best and we will have to see and wait.
